New York – Every now and then you go to a cancer conference and instead of hearing the expected standard talk that is repeated time and time again for a season or so, you are delighted with a more engaging and uninhibited approach that captivates and informs on the latest state of the art progress.
It also means that more than the presenter realises is perhaps shared. That’s very good news indeed for intrepid science writers and anyone who cares to listen or read.
The research mentioned in today’s post falls in the engaged and delighted category…
To learn more from our latest assessment and get a heads up on our oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.